Literature DB >> 12665269

The clinical efficacy of fluticasone propionate (Fluvent) compared with beclomethasone dipropionates (Becotide) in patients with mild to moderate brochial asthma at the University College Hospital, Ibadan, Nigeria.

O M Ige1, O M Sogaolu.   

Abstract

This open, randomized trial was conducted at the Medical Out patient Department of University College Hospital, Nigeria to compare the clinical efficacy of Beclomethasome dipropionate (Becotide) with Fluticasone propionate (Fluvent) in patients with mild to moderate bronchial asthma. The study was performed as a week screening, 8-weeks open comparative clinical trial involving Fluticasone propionate (Fluvent) at a daily dose of 22 microg and Beclomethasone Dipropionate (Becotide) at a dose of 400 microg daily delivered through pressurized metered-dose inhaler (pMDI). The main objective of this study is to assess the efficacy of Fluvent in patients with mild to moderate asthma compared to Becotide. At the second visit (end of 1 week), 10 patients were given either Becotide of Fluvent but all were maintained on as needed beta2agonist (Salbutamol inhaler) therapy throughout the study. Efficacy was assessed by changes in symptoms, number of times beta2-agonist was used and results of pulmonary function tests (PEFR and FEV1) while safety was assessed by adverse event experiences. The baseline characteristics of the patients randomized into the two drug groups were comparable and of no statistical significance. The changes in the pulmonary function tests as well as the reduction in the asthma symptoms suggest a statistically significant improvement in the asthma status of the patients. However, these changes were more rapid among the patients using Fluvent. Also, there was higher percentage decline in the episodes of asthma symptoms either in the morning, day or night in the Fluvent group than Becotide group. The drugs were well tolerated and no adverse event was noticed on any of the patients. We therefore concluded that Fluvent would be more efficacious than Becotide in the treatment of Asthma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12665269     DOI: 10.4314/wajm.v21i4.28003

Source DB:  PubMed          Journal:  West Afr J Med        ISSN: 0189-160X


  2 in total

1.  Influence of delivery devices on efficacy of inhaled fluticasone propionate: a comparative study in stable asthma patients.

Authors:  Bhanu Prakash Kolasani; Venu Madhavi Lanke; Sudheer Diyya
Journal:  J Clin Diagn Res       Date:  2013-09-10

2.  Health-related quality of life assessment using St. George's respiratory questionnaire in asthmatics on inhaled corticosteroids.

Authors:  Thomas Sabin; Gurumurthy Parthasarathi; Mahesh A Padukudru
Journal:  Lung India       Date:  2012-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.